fbpx

The Lundbeck Foundation pledges DKK 30 million to coronavirus research

The Lundbeck Foundation has decided to earmark DKK 30 million for research projects targeting the current coronavirus pandemic. We are doing so because of the highly exceptional and acute situation in which society finds itself. Focused efforts are required from all social stakeholders, and this includes the research-funding commercial foundations.

‘In the view of the Lundbeck Foundation, new knowledge is absolutely crucial to enable us to take action on an informed basis, and this is reflected in our approach to the COVID-19 pandemic. Our aspiration with this grant is to help mitigate the impact of the current pandemic on Denmark, for the good of patients, their relatives and society in general,’ says Lene Skole, CEO of the Lundbeck Foundation.

The Lundbeck Foundation focuses on biomedical sciences and, in particular, research into brain disorders. However, due to the current situation, we have decided to provide funding for biomedical science research activities with the potential to mitigate the impact of the COVID-19 pandemic.

The funding is available for research-based projects with a patient focus. Projects must have the potential for direct impact in this acute situation and therefore be able to be initiated without delay.

It is possible to apply for up to DKK 5 million per project. Applications will be assessed on an ongoing basis and we will endeavour to respond within 48 hours.

Applicants must be affiliated with Danish universities or hospitals and, in this special case, with local authorities, patient associations, think-tanks or similar organisations.

Further details:

Jan Egebjerg, Director of Research, tel. +45 2119 3713
Regitze Reeh, Head of Communications, tel. +45 3054 6608

What You Can Apply For

 

News

Seven research institutions receive DKK 20 million for coronavirus research
1. April 2020
How we handle changes to research projects in light of the coronavirus pandemic
31. March 2020
Lundbeck Foundation gives its first coronavirus grant to trial with a known drug
26. March 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge